PenderFund Capital Management »

Freeline Therapeutics Holdings shares owned by PenderFund Capital Management

Quarter-by-quarter ownership of Freeline Therapeutics Holdings shares owned by PenderFund Capital Management from 13F filings

Historical chart of PenderFund Capital Management investment in Freeline Therapeutics Holdings

Tip: Access up to 7 years of quarterly data

All positions including Freeline Therapeutics Holdings held by PenderFund Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Freeline Therapeutics Holdings by PenderFund Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $509k 60k 8.43

More positions owned by PenderFund Capital Management

Esperion Therapeutics Inc Ne Note 4.000%11/1 (Principal)
First Majestic Silver Corp Note 0.375% 1/1 (Principal)
Ssr Mining In Note 2.500% 4/0 (Principal)
Opko Health Note 4.500% 2/1 (Principal)
Bandwidth Note 0.500% 4/0 (Principal)
PAR Technology Corporation (PAR)
Burford Cap Ord Shs (BUR)
Sangoma Technologies Corp Com New (SANG)
Nuveen Insured Tax-Free Adv Munici (NEA)
Nuveen Div. Advantage Muni. Fund (NAD)
Nuveen Municipal Credit Com Sh Ben Int (NZF)
Nuveen Insd Dividend Advantage (NVG)
Docebo (DCBO)
Kkr & Co (KKR)
Morgan Stanley Emerging Markets Domestic (EDD)

View all positions for PenderFund Capital Management

Top funds holding Freeline Therapeutics Holdings

UBS Group
Blue Owl Capital Holdings
Jpmorgan Chase & Co
PenderFund Capital Management
Harbor Capital Advisors
Sphera Funds Management
Rhumbline Advisers

View all funds holding Freeline Therapeutics Holdings